Status:

COMPLETED

Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

Breast Cancer

Mastectomy

Eligibility:

FEMALE

19+ years

Phase:

EARLY_PHASE1

Brief Summary

The purpose of this study is to see if pre-operative regional nerve blocks compared to a placebo nerve block can decrease chronic post mastectomy pain, immediate postoperative pain and postoperative n...

Detailed Description

Surgical intervention of breast cancer is vital to breast cancer treatment or prevention and patient outcomes. However, surgical therapy can lead to chronic pain that may affect quality of life for br...

Eligibility Criteria

Inclusion

  • Women at least 19 years old who are able to provide written and informed consent
  • Women undergoing unilateral or bilateral, simple, skin-sparing, or nipple sparing mastectomy for breast cancer (Stage 0-III) or breast cancer prevention
  • Patients with ASA class of I-III will be included

Exclusion

  • Stage IV breast cancer, morbid obesity with BMI \>45kg/m2
  • Renal insufficiency (Creatinine \>1.5 mg/dL)
  • Current chronic analgesic use (daily use for \> or equal to 4 weeks)
  • History of opioid abuse or dependence
  • Presence of chronic pain with a self-reported average pain score of 4 or greater on a pain scale of 0-10 prior to any surgical intervention
  • Incarceration
  • Pregnancy
  • Immediate autologous tissue reconstruction.

Key Trial Info

Start Date :

July 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 25 2021

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT04019834

Start Date

July 6 2020

End Date

November 25 2021

Last Update

August 3 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alabama at Birmingham Hospitals and Affiliated Clinics

Birmingham, Alabama, United States, 35233